Global Nanobody Sequence Library Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08244307

Publication Date:

August 7, 2024

Pages:

118

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Nanobody (Nb) is an artificially designed antibody molecule, also known as single-domain antibodies (sdAbs), VHH antibodies or camelid antibodies. It is a kind of heavy-chain antibodies (HCAbs) that naturally lack light chains and are found in camelids such as alpacas and dromedaries, as well as cartilaginous fish such as sharks and rays. There are monovalent nanobodies, bivalent nanobodies, bispecific nanobodies, multivalent nanobodies and fused nanobodies.
The global Nanobody Sequence Library market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淣anobody Sequence Library Industry Forecast鈥� looks at past sales and reviews total world Nanobody Sequence Library sales in 2022, providing a comprehensive analysis by region and market sector of projected Nanobody Sequence Library sales for 2023 through 2029. With Nanobody Sequence Library sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nanobody Sequence Library industry.
This Insight Report provides a comprehensive analysis of the global Nanobody Sequence Library landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nanobody Sequence Library portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Nanobody Sequence Library market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nanobody Sequence Library and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nanobody Sequence Library.
United States market for Nanobody Sequence Library is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Nanobody Sequence Library is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Nanobody Sequence Library is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Nanobody Sequence Library players cover GenScript ProBio, Abiocenter, Abace Biotechnology, KMDTM Bioscience, Sino Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Nanobody Sequence Library market by product type, application, key players and key regions and countries.
Segmentation by Type:
Immune Library
Natural Library
Fully Synthetic Library
Segmentation by Application:
Drug Development
Vaccine Research
Biosensors
Tumor Treatment
Diagnostic Tools
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Immune Library
Natural Library
Fully Synthetic Library
Segmentation by Application:
Drug Development
Vaccine Research
Biosensors
Tumor Treatment
Diagnostic Tools
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GenScript ProBio
Abiocenter
Abace Biotechnology
KMDTM Bioscience
Sino Biologics
WuXi Biologics
Creative Biolabs
Twist Bioscience
ProteoGenix
Fortis Life Sciences
Synbio Technologies
KMD Bioscience

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nanobody Sequence Library Market Size 2019-2030
2.1.2 Nanobody Sequence Library Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Nanobody Sequence Library by Country/Region, 2019, 2023 & 2030
2.2 Nanobody Sequence Library Segment by Type
2.2.1 Immune Library
2.2.2 Natural Library
2.2.3 Fully Synthetic Library
2.3 Nanobody Sequence Library Market Size by Type
2.3.1 Nanobody Sequence Library Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nanobody Sequence Library Market Size Market Share by Type (2019-2024)
2.4 Nanobody Sequence Library Segment by Application
2.4.1 Drug Development
2.4.2 Vaccine Research
2.4.3 Biosensors
2.4.4 Tumor Treatment
2.4.5 Diagnostic Tools
2.5 Nanobody Sequence Library Market Size by Application
2.5.1 Nanobody Sequence Library Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nanobody Sequence Library Market Size Market Share by Application (2019-2024)
3 Nanobody Sequence Library Market Size by Player
3.1 Nanobody Sequence Library Market Size Market Share by Player
3.1.1 Global Nanobody Sequence Library Revenue by Player (2019-2024)
3.1.2 Global Nanobody Sequence Library Revenue Market Share by Player (2019-2024)
3.2 Global Nanobody Sequence Library Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nanobody Sequence Library by Region
4.1 Nanobody Sequence Library Market Size by Region (2019-2024)
4.2 Global Nanobody Sequence Library Annual Revenue by Country/Region (2019-2024)
4.3 Americas Nanobody Sequence Library Market Size Growth (2019-2024)
4.4 APAC Nanobody Sequence Library Market Size Growth (2019-2024)
4.5 Europe Nanobody Sequence Library Market Size Growth (2019-2024)
4.6 Middle East & Africa Nanobody Sequence Library Market Size Growth (2019-2024)
5 Americas
5.1 Americas Nanobody Sequence Library Market Size by Country (2019-2024)
5.2 Americas Nanobody Sequence Library Market Size by Type (2019-2024)
5.3 Americas Nanobody Sequence Library Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nanobody Sequence Library Market Size by Region (2019-2024)
6.2 APAC Nanobody Sequence Library Market Size by Type (2019-2024)
6.3 APAC Nanobody Sequence Library Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nanobody Sequence Library Market Size by Country (2019-2024)
7.2 Europe Nanobody Sequence Library Market Size by Type (2019-2024)
7.3 Europe Nanobody Sequence Library Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nanobody Sequence Library by Region (2019-2024)
8.2 Middle East & Africa Nanobody Sequence Library Market Size by Type (2019-2024)
8.3 Middle East & Africa Nanobody Sequence Library Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nanobody Sequence Library Market Forecast
10.1 Global Nanobody Sequence Library Forecast by Region (2025-2030)
10.1.1 Global Nanobody Sequence Library Forecast by Region (2025-2030)
10.1.2 Americas Nanobody Sequence Library Forecast
10.1.3 APAC Nanobody Sequence Library Forecast
10.1.4 Europe Nanobody Sequence Library Forecast
10.1.5 Middle East & Africa Nanobody Sequence Library Forecast
10.2 Americas Nanobody Sequence Library Forecast by Country (2025-2030)
10.2.1 United States Market Nanobody Sequence Library Forecast
10.2.2 Canada Market Nanobody Sequence Library Forecast
10.2.3 Mexico Market Nanobody Sequence Library Forecast
10.2.4 Brazil Market Nanobody Sequence Library Forecast
10.3 APAC Nanobody Sequence Library Forecast by Region (2025-2030)
10.3.1 China Nanobody Sequence Library Market Forecast
10.3.2 Japan Market Nanobody Sequence Library Forecast
10.3.3 Korea Market Nanobody Sequence Library Forecast
10.3.4 Southeast Asia Market Nanobody Sequence Library Forecast
10.3.5 India Market Nanobody Sequence Library Forecast
10.3.6 Australia Market Nanobody Sequence Library Forecast
10.4 Europe Nanobody Sequence Library Forecast by Country (2025-2030)
10.4.1 Germany Market Nanobody Sequence Library Forecast
10.4.2 France Market Nanobody Sequence Library Forecast
10.4.3 UK Market Nanobody Sequence Library Forecast
10.4.4 Italy Market Nanobody Sequence Library Forecast
10.4.5 Russia Market Nanobody Sequence Library Forecast
10.5 Middle East & Africa Nanobody Sequence Library Forecast by Region (2025-2030)
10.5.1 Egypt Market Nanobody Sequence Library Forecast
10.5.2 South Africa Market Nanobody Sequence Library Forecast
10.5.3 Israel Market Nanobody Sequence Library Forecast
10.5.4 Turkey Market Nanobody Sequence Library Forecast
10.6 Global Nanobody Sequence Library Forecast by Type (2025-2030)
10.7 Global Nanobody Sequence Library Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Nanobody Sequence Library Forecast
11 Key Players Analysis
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Information
11.1.2 GenScript ProBio Nanobody Sequence Library Product Offered
11.1.3 GenScript ProBio Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 GenScript ProBio Main Business Overview
11.1.5 GenScript ProBio Latest Developments
11.2 Abiocenter
11.2.1 Abiocenter Company Information
11.2.2 Abiocenter Nanobody Sequence Library Product Offered
11.2.3 Abiocenter Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Abiocenter Main Business Overview
11.2.5 Abiocenter Latest Developments
11.3 Abace Biotechnology
11.3.1 Abace Biotechnology Company Information
11.3.2 Abace Biotechnology Nanobody Sequence Library Product Offered
11.3.3 Abace Biotechnology Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Abace Biotechnology Main Business Overview
11.3.5 Abace Biotechnology Latest Developments
11.4 KMDTM Bioscience
11.4.1 KMDTM Bioscience Company Information
11.4.2 KMDTM Bioscience Nanobody Sequence Library Product Offered
11.4.3 KMDTM Bioscience Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 KMDTM Bioscience Main Business Overview
11.4.5 KMDTM Bioscience Latest Developments
11.5 Sino Biologics
11.5.1 Sino Biologics Company Information
11.5.2 Sino Biologics Nanobody Sequence Library Product Offered
11.5.3 Sino Biologics Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sino Biologics Main Business Overview
11.5.5 Sino Biologics Latest Developments
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Information
11.6.2 WuXi Biologics Nanobody Sequence Library Product Offered
11.6.3 WuXi Biologics Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 WuXi Biologics Main Business Overview
11.6.5 WuXi Biologics Latest Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Company Information
11.7.2 Creative Biolabs Nanobody Sequence Library Product Offered
11.7.3 Creative Biolabs Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Creative Biolabs Main Business Overview
11.7.5 Creative Biolabs Latest Developments
11.8 Twist Bioscience
11.8.1 Twist Bioscience Company Information
11.8.2 Twist Bioscience Nanobody Sequence Library Product Offered
11.8.3 Twist Bioscience Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Twist Bioscience Main Business Overview
11.8.5 Twist Bioscience Latest Developments
11.9 ProteoGenix
11.9.1 ProteoGenix Company Information
11.9.2 ProteoGenix Nanobody Sequence Library Product Offered
11.9.3 ProteoGenix Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 ProteoGenix Main Business Overview
11.9.5 ProteoGenix Latest Developments
11.10 Fortis Life Sciences
11.10.1 Fortis Life Sciences Company Information
11.10.2 Fortis Life Sciences Nanobody Sequence Library Product Offered
11.10.3 Fortis Life Sciences Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fortis Life Sciences Main Business Overview
11.10.5 Fortis Life Sciences Latest Developments
11.11 Synbio Technologies
11.11.1 Synbio Technologies Company Information
11.11.2 Synbio Technologies Nanobody Sequence Library Product Offered
11.11.3 Synbio Technologies Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Synbio Technologies Main Business Overview
11.11.5 Synbio Technologies Latest Developments
11.12 KMD Bioscience
11.12.1 KMD Bioscience Company Information
11.12.2 KMD Bioscience Nanobody Sequence Library Product Offered
11.12.3 KMD Bioscience Nanobody Sequence Library Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 KMD Bioscience Main Business Overview
11.12.5 KMD Bioscience Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂